This page contains a Flash digital edition of a book.
We care about patients with haemophilia Passion for a brighter future!


Sobi is a leading, innovative European biopharmaceutical company. We are dedicated to bringing new therapies and services to patients with rare diseases. Our capabilities reach from preclinical and clinical development through to manufacturing, marketing and sales.


In haemophilia Sobi has a simple goal – to ensure that people with haemophilia live the life they wish for and deserve, full of the experiences they desire. Sobi through our predecessors, have a long tradition of haemophilia research and development. This heritage coupled with our commitment, drives us towards innovation for improved treatment for haemophilia.


SOBIUK/HAEM/2013/0004. Date of preparation: January 2013.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36